Who Owns Sarepta Therapeutics Stock?
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 99.31%
- Institutions (% of float)
- 104.33%
- Held by insiders
- 4.81%
- Institutional holders
- 414
- Institutions 95.2%
- Insiders 4.8%
- Public and other 0.0%
Who owns Sarepta Therapeutics stock?
Institutional investors own about 99.3% of Sarepta Therapeutics's shares, spread across 414 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.81% of SRPT.
The largest institutional holders are Blackrock Inc. (17.51%), Vanguard Portfolio Management LLC (8.11%) and State Street Corporation (6.91%). Together, the top 10 institutions control 55.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their SRPT positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SRPT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 18.78M | 17.51% | -1.1% |
| Vanguard Portfolio Management LLC | 8.70M | 8.11% | +3.8% |
| State Street Corporation | 7.41M | 6.91% | -16.9% |
| First Trust Advisors LP | 4.92M | 4.59% | +12.8% |
| Vanguard Capital Management LLC | 4.60M | 4.29% | +0.1% |
| Two Sigma Investments, LP | 4.48M | 4.17% | -2.7% |
| Goldman Sachs Group Inc | 3.28M | 3.06% | +60.5% |
| Geode Capital Management, LLC | 2.69M | 2.51% | -3.1% |
| Balyasny Asset Management LP | 2.45M | 2.29% | +1510.6% |
| Erste Asset Management GmbH | 2.27M | 2.12% | -11.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SRPT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.29M | 5.86% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 4.78M | 4.46% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19M | 2.97% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.96M | 2.76% |
| iShares Trust-iShares Russell 2000 ETF | 2.69M | 2.51% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.30M | 2.14% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.33M | 1.24% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.20M | 1.12% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.14M | 1.06% |
| Federated Hermes Equity Funds-Federated Hermes MDT Mid Cap Growth Fund | 1.11M | 1.03% |
Frequently asked questions
Who is the largest shareholder of Sarepta Therapeutics?
Blackrock Inc. is the largest institutional shareholder of SRPT, owning 17.51% of shares outstanding (18.78M shares) as of its latest 13F filing.
What percentage of Sarepta Therapeutics is owned by institutions?
Institutions own about 99.3% of SRPT shares and 104.3% of the public float.
How much of Sarepta Therapeutics do insiders own?
Insiders, such as officers and directors, own about 4.81% of SRPT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.